Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Next-generation Sequencing03:00

Next-generation Sequencing

97.7K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.7K
Sanger Sequencing01:57

Sanger Sequencing

773.0K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
773.0K
Genomic DNA in Eukaryotes00:58

Genomic DNA in Eukaryotes

52.2K
Eukaryotes have large genomes compared to prokaryotes. To fit their genomes into a cell, eukaryotic DNA is packaged extraordinarily tightly inside the nucleus. To achieve this, DNA is tightly wound around proteins called histones, which are packaged into nucleosomes that are joined by linker DNA and coil into chromatin fibers. Additional fibrous proteins further compact the chromatin, which is recognizable as chromosomes during certain phases of cell division.
52.2K
DNA Isolation01:24

DNA Isolation

44.4K
DNA isolation protocols can be fast and straightforward or complex and time-consuming depending on the type and quality of DNA required for further processing. For example, plasmid DNA extraction is a bit more complicated than genomic DNA extraction because of the need for an appropriate lysis method to separate plasmid DNA from gDNA during isolation. However, for specific applications, such as long-range DNA sequencing that require a good yield of high- quality DNA samples, we need to follow...
44.4K
DNA Isolation01:34

DNA Isolation

198.9K
DNA from cells is required for many biotechnology and research applications, such as molecular cloning. To remove and purify DNA from cells, researchers use various methods of DNA extraction. While the specifics of different protocols may vary, some general concepts underlie the process of DNA extraction.
198.9K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Sequencing of Pleural Fluid and Plasma for Tuberculous Pleuritis.

NEJM evidence·2026
Same author

Holistic determination of ends of cfDNA molecules.

Cell genomics·2026
Same author

Checking Up on the King of Cancers.

Cancer discovery·2026
Same author

Clinical Variables and Cell-Free DNA Fragmentomics: Biological and Clinical Insights.

Clinical chemistry·2026
Same author

Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo Correction.

American journal of human genetics·2025
Same author

The comings and goings of cell-free DNA: Biological and clinical implications.

Med (New York, N.Y.)·2025

Video Experimental Relacionado

Updated: Jan 13, 2026

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.7K

ADN libre circulante en 2030

W H Adrian Tsui1, Y M Dennis Lo2

  • 1Centre for Novostics, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong SAR, China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China; Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.

Med (New York, N.Y.)
|January 10, 2026
PubMed
Resumen

El análisis de ADN libre circulante (cfDNA) avanza en las biopsias líquidas. Los avances recientes en la biología del cfDNA, las técnicas de laboratorio y los datos clínicos ofrecen aplicaciones futuras prometedoras en este campo mínimamente invasivo.

Palabras clave:
ADN libre circulantebiopsia líquidadiagnóstico del cáncergenómicamedicina de precisión

Más Videos Relacionados

Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

14.2K
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.5K

Videos de Experimentos Relacionados

Last Updated: Jan 13, 2026

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.7K
Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

14.2K
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.5K

Área de la Ciencia:

  • Bioquímica
  • Biología Molecular
  • Genómica

Sus antecedentes:

  • El análisis de ADN libre circulante (cfDNA) es crucial para las biopsias líquidas mínimamente invasivas.
  • Se han logrado avances significativos en la comprensión de la biología del cfDNA durante los últimos cinco años.
  • El campo ha visto innovaciones tanto en las metodologías de laboratorio (húmedo) como de análisis de datos (seco).

Objetivo del estudio:

  • Resumir los avances clave en el análisis de cfDNA durante los últimos cinco años.
  • Discutir las perspectivas futuras del cfDNA en biopsias líquidas para los próximos cinco años.
  • Destacar las innovaciones en la biología del cfDNA, los enfoques de laboratorio húmedo y seco.

Principales métodos:

  • Revisión de la literatura reciente sobre el análisis de cfDNA.
  • Síntesis de hallazgos relacionados con la biología del cfDNA.
  • Análisis de innovaciones en técnicas experimentales y computacionales.
  • Examen de datos acumulados de resultados clínicos.

Principales resultados:

  • Profundización de la comprensión de la biología fundamental del cfDNA.
  • Desarrollo de nuevas técnicas de laboratorio húmedo y seco para el análisis de cfDNA.
  • Acumulación de datos sustanciales de resultados clínicos asociados con el análisis de cfDNA.
  • Identificación de áreas clave para la investigación y el desarrollo futuros.

Conclusiones:

  • El análisis de cfDNA ha madurado significativamente como un componente central de las biopsias líquidas.
  • Las innovaciones en la metodología y la comprensión biológica allanan el camino para una utilidad clínica ampliada.
  • El campo está preparado para un crecimiento y aplicación continuos en diagnóstico y pronóstico.